The content discusses the growing concerns around endocrine-disrupting compounds (EDCs) and their impact on human health. It highlights the following key points:
EDCs are a diverse array of artificial compounds that can interfere with every aspect of hormonal action, leading to a wide range of health issues, including hormone-sensitive tumors, fetal neurological development alterations, infertility, metabolic disorders, and immune system changes.
The economic burden of EDCs on public health in the United States is estimated to be $250 billion, or 1% of the country's GDP, and a similar burden has been calculated for Europe.
Avoiding exposure to EDCs is extremely difficult as they are present in almost every object in our daily lives, from plastics to building materials, and they persist in the environment and accumulate in the body.
Regulatory agencies in Europe are taking action, such as the European Chemicals Agency (ECHA) proposing restrictions on flame retardants and PFAS, and the European Food Safety Authority (EFSA) lowering the recommended exposure limits for bisphenol-A by a significant margin.
However, the industry often responds by creating new compounds that can be equally dangerous, and the combined effects of exposure to multiple EDCs are not yet fully understood.
Exposure to EDCs is not equal, with certain populations, such as workers in the plastic industry, cleaning services, construction, and agriculture, facing higher levels of exposure and associated health risks.
Addressing the challenge of EDCs requires a multifaceted approach, including increased awareness and advocacy from the medical community, as well as policy changes aimed at decarbonizing and detoxifying the economy.
To Another Language
from source content
www.medscape.com
Ключевые выводы из
by Massimo Sand... в www.medscape.com 04-18-2024
https://www.medscape.com/viewarticle/endocrine-disruptors-pose-challenges-human-health-2024a10007ihДополнительные вопросы